Literature DB >> 17293496

Losartan prevents stretch-induced electrical remodeling in cultured atrial neonatal myocytes.

Erol Saygili1, Obaida R Rana, Esra Saygili, Hannes Reuter, Konrad Frank, Robert H G Schwinger, Jochen Müller-Ehmsen, Carsten Zobel.   

Abstract

Atrial fibrillation (AF) is the most frequent arrhythmia found in clinical practice. In recent studies, a decrease in the development or recurrence of AF was found in hypertensive patients treated with angiotensin-converting enzyme inhibitors or angiotensin receptor-blocking agents. Hypertension is related to an increased wall tension in the atria, resulting in increased stretch of the individual myocyte, which is one of the major stimuli for the remodeling process. In the present study, we used a model of cultured atrial neonatal rat cardiomyocytes under conditions of stretch to provide insight into the mechanisms of the preventive effect of the angiotensin receptor-blocking agent losartan against AF on a molecular level. Stretch significantly increased protein-to-DNA ratio and atrial natriuretic factor mRNA expression, indicating hypertrophy. Expression of genes encoding for the inward rectifier K(+) current (I(K1)), Kir 2.1, and Kir 2.3, as well as the gene encoding for the ultrarapid delayed rectifier K(+) current (I(Kur)), Kv 1.5, was significantly increased. In contrast, mRNA expression of Kv 4.2 was significantly reduced in stretched myocytes. Alterations of gene expression correlated with the corresponding current densities: I(K1) and I(Kur) densities were significantly increased in stretched myocytes, whereas transient outward K(+) current (I(to)) density was reduced. These alterations resulted in a significant abbreviation of the action potential duration. Losartan (1 microM) prevented stretch-induced increases in the protein-to-DNA ratio and atrial natriuretic peptide mRNA expression in stretched myocytes. Concomitantly, losartan attenuated stretch-induced alterations in I(K1), I(Kur), and I(to) density and gene expression. This prevented the stretch-induced abbreviation of action potential duration. Prevention of stretch-induced electrical remodeling might contribute to the clinical effects of losartan against AF.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17293496     DOI: 10.1152/ajpheart.00546.2006

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  15 in total

1.  Left atrial pressure and dominant frequency of atrial fibrillation in humans.

Authors:  Kentaro Yoshida; Magnus Ulfarsson; Hakan Oral; Thomas Crawford; Eric Good; Krit Jongnarangsin; Frank Bogun; Frank Pelosi; Jose Jalife; Fred Morady; Aman Chugh
Journal:  Heart Rhythm       Date:  2010-10-26       Impact factor: 6.343

2.  Cardiac electrophysiology delivered a "grand slam" by angiotensin II: the third explanation of transmural cardiac electrical activity gradients.

Authors:  Donald W Hilgemann
Journal:  Biophys J       Date:  2014-06-03       Impact factor: 4.033

3.  Crosstalk between the angiotensin and endothelin system in the cerebrovasculature after experimental induced subarachnoid hemorrhage.

Authors:  Stefan Wanderer; Jan Mrosek; Hartmut Vatter; Volker Seifert; Juergen Konczalla
Journal:  Neurosurg Rev       Date:  2017-07-29       Impact factor: 3.042

4.  Sympathetic neurons express and secrete MMP-2 and MT1-MMP to control nerve sprouting via pro-NGF conversion.

Authors:  Erol Saygili; Patrick Schauerte; Maimouna Pekassa; Esra Saygili; Gediminas Rackauskas; Robert H G Schwinger; Joachim Weis; Christian Weber; Nikolaus Marx; Obaida R Rana
Journal:  Cell Mol Neurobiol       Date:  2010-08-04       Impact factor: 5.046

5.  Age-related regional differences in cardiac nerve growth factor expression.

Authors:  Erol Saygili; Rahel Kluttig; Obaida R Rana; Esra Saygili; Christopher Gemein; Matthias D Zink; Gediminas Rackauskas; Joachim Weis; Robert H G Schwinger; Nikolaus Marx; Patrick Schauerte
Journal:  Age (Dordr)       Date:  2011-05-11

6.  A novel double cryoballoon strategy in persistent atrial fibrillation: a pilot study.

Authors:  Martin Schmidt; Uwe Dorwarth; Florian Straube; Michael Wankerl; Jürgen Krieg; Alexander W Leber; Hans Ullrich Ebersberger; Marcos Daccarett; Armin Huber; Ernst Rummeny; Ellen Hoffmann
Journal:  Clin Res Cardiol       Date:  2012-04-09       Impact factor: 5.460

7.  The Effect of Substrate Stiffness on Cardiomyocyte Action Potentials.

Authors:  Sean D Boothe; Jackson D Myers; Seokwon Pok; Junping Sun; Yutao Xi; Raymond M Nieto; Jie Cheng; Jeffrey G Jacot
Journal:  Cell Biochem Biophys       Date:  2016-10-08       Impact factor: 2.194

Review 8.  Mechanobiology of cardiomyocyte development.

Authors:  Jeffrey G Jacot; Jody C Martin; Darlene L Hunt
Journal:  J Biomech       Date:  2009-10-12       Impact factor: 2.712

Review 9.  Non-antiarrhythmic medications for atrial fibrillation: from bench to clinical practice.

Authors:  Maya Guglin; Marcos Garcia; Michael J Yarnoz; Anne B Curtis
Journal:  J Interv Card Electrophysiol       Date:  2008-03-04       Impact factor: 1.900

10.  Mechanisms with clinical implications for atrial fibrillation-associated remodeling: cathepsin K expression, regulation, and therapeutic target and biomarker.

Authors:  Masaya Fujita; Xian W Cheng; Yasuya Inden; Masayuki Shimano; Naoki Yoshida; Aiko Inoue; Toshihiko Yamamoto; Kyosuke Takeshita; Seifuku Kyo; Noriko Taguchi; Guo-Ping Shi; Masafumi Kuzuya; Kenji Okumura; Toyoaki Murohara
Journal:  J Am Heart Assoc       Date:  2013-12-16       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.